Business Daily from THE HINDU group of publications
Thursday, Mar 05, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Regulatory Bodies & Rulings
Aurobindo drug gets US FDA nod

Hyderabad, March 4

Aurobindo Pharma Ltd has received tentative approval for anti-depressant drug, Escitalopram Oxalate tablets, from the US Food and Drug Administration (US FDA). The Escitalopram Oxalate tablets are the general equivalent of Forest Laboratories Inc's Lexapro tablets, which fall under the Central Nervous System (CNS) segment. It is indicated for treatment of depression associated with mood disorders. The market size of the drug is estimated at $2.6 billion for the 12 months ended September 2008, the Hyderabadbased company said in a release. - Our Bureau

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Project in Chennai: DLF working out a scheme to refund EMD

Kalpataru Power bags PowerGrid order
Areva T&D gets Rs 60-cr deal
ITT consortium wins $22-m deal in AP
Tata Steel bags Global Peacock
Moody’s downgrades Tata Steel
IOC may sell bonds worth Rs 1,500 cr
Philips Healthcare targets mid-price segment through more acquisitions
DLF to invest Rs 2,500 cr in projects near Chennai
Zydus unit gets accreditation
Aurobindo drug gets US FDA nod
BEML in pact with Indonesian firm for mining biz
Security biz gearing up to tap opportunities
Low prices may hamper NELP VIII: Reliance
ONGC sees scope to negotiate with shipyards for lower prices
Tube Investments to focus on retail
NTPC to borrow funds for expansion
United Spirits may place curbs on partner’s holding in company
TN plant to make Italian tractors for sale in China
Satyam crisis might hit our biz: SanDisk
Ashok Leyland Feb sales down 57%


eWorld
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line